drugset / Trial / NCT02593383

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

NCT02593383

Phase 1/2 Completed 245 enrolled Lee's Pharmaceutical Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

evaluate the safety and efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in treatment of chinese patients with acne.

Timeline

Start
2015-03-01
Primary completion
2017-07-31
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.05 %
Subject Adapalene Other / unclassified 0.1 %
Subject Clindamycin Unknown 0.5 %
Subject Clindamycin Unknown 1 %
Subject Clindamycin Unknown 2 %

Indications